A novel smad3 splice variant as a target in chronic renal...

C - Chemistry – Metallurgy – 12 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12N 15/12 (2006.01) A61K 31/70 (2006.01) A61K 38/17 (2006.01) A61K 48/00 (2006.01) C07K 14/47 (2006.01) C07K 16/18 (2006.01) C12Q 1/68 (2006.01) G01N 33/53 (2006.01) A61K 38/00 (2006.01) A61K 39/00 (2006.01)

Patent

CA 2238670

sMAD3d polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing sMAD3d polypeptides and polynucleotides in the design of protocols for the treatment of chronic renal failure, atherosclerosis, and fibrosis, among others, and diagnostic assays for such conditions.

Divulgation de polypeptides et de polynucléotides sMAD3d, ainsi que de méthodes de production de tels polypeptides par des techniques de recombinaison. Des méthodes pour utiliser les polypeptides et les polynucléotides sMAD3d dans la conception de protocoles pour le traitement de l'insuffisance rénale chronique, de l'athérosclérose et de la fibrose, entre autres, de même que des épreuves diagnostiques pour ces conditions sont également dévoilées.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

A novel smad3 splice variant as a target in chronic renal... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with A novel smad3 splice variant as a target in chronic renal..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and A novel smad3 splice variant as a target in chronic renal... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1517334

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.